CTRI/2023/03/050470CompletedUnknown
Pilot Study Clinical Trial to Evaluate the Safety and Efficacy of Robotic Surgery System for Minimum Access Surgical Procedures
Max Hospital Vaishali0 sites20 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients who meet the surgical indications and need minimally invasive cholecystectomy, appendectomy, abdominal hernia repair, bariatric or gastrointestinal surgery.Volunteered to participate in this trial and signed the informed consent.
Exclusion Criteria
- •1. Those who cannot tolerate or establish pneumoperitoneum.
- •2. Severe heart, lung, liver, and kidney disease who cannot tolerate surgery.
- •3. Those who need emergency surgery due to illness.
- •4. History of continuous systemic corticosteroid or immunosuppressive therapy within the past 1 mon. 5. The patient is mentally incapable to understand the requirements and consequences of the study.
- •6. Pregnant and lactating women.
- •7. The patient is unwilling or unable to comply with the doctor orders.
- •8. Those who have participated in clinical trials within the past three months.
- •9. Extremes of age (Less than 18 years or more than 75 years)
- •10. Other conditions deemed inappropriate by the PI and medical staff.
Investigators
Similar Trials
Not yet recruiting
Phase 2
Clinical study of nutritional supplement Supply6 360 to improve gut health.CTRI/2024/03/063507Kanari Nutrition Pvt. Ltd.
Not yet recruiting
Phase 2
Evaluation of Siddha formulations Nuflm-1 capsule, Spln-2 softgel and Rudn oil-3 in the treatment of neck pain and backpain with sciatica.CTRI/2024/03/064253il
Completed
Not Applicable
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted with MPLA Liposomes, in Healthy, HIV-Uninfected AdultsNL-OMON48531Academisch Medisch Centrum24
Completed
Not Applicable
Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults-B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesB20PER-052-06INSTITUTO NACIONAL DE ALERGIAS Y ENFERMEDADES INFECCIOSAS DE LOS ESTADOS UNIDOS,
Completed
Not Applicable
Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults-Z21 Asymptomatic human immunodeficiency virus [HIV] infection statusAsymptomatic human immunodeficiency virus [HIV] infection statusZ21PER-065-06ational Health Institute(Division Sida),